Apolipoproteins as markers and managers of coronary risk

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026 · see citing works

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992 · see citing works

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902 · see citing works

The metabolic syndrome

Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,283 · see citing works

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938 · see citing works

Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489 · see citing works

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550 · see citing works

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

Walldius, G., Jungner, I., Holme, I., AASTVEIT, A. H., Kolar, W., & Steiner, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07098-2 · Cited by 1,227 · see citing works

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study

Yusuf, S., Hawken, S., & Ôunpuu, S. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.11.072 · Cited by 1,146 · see citing works

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

Ridker, P., Rifai, N., Cook, N., Bradwin, G., & Buring, J. (2005) · Journal of the American Medical Association (JAMA) · doi:10.1016/j.accreview.2005.09.030 · Cited by 832 · see citing works

Non–HDL Cholesterol, Apolipoproteins A-I and B ₁₀₀ , Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women

Ridker, P. M., Rifai, N., Cook, N. R., Bradwin, G., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.3.326 · Cited by 744 · see citing works

Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime

Steinberg, D. H. (2002) · Nature Medicine · doi:10.1038/nm1102-1211 · Cited by 679 · see citing works

Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality

Cui, Y. A., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., LANGENBERG, P. W., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 657 · see citing works

Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

Pedersen, T. R., OLSSON, A. G., Færgeman, O., KJEKSHUS, J. K., Wedel, H., Berg, K., Wilhelmsen, L., Haghfelt, T. H., Þorgeirsson, G., Pyörälà, K., et al. (1998) · Circulation · doi:10.1161/01.cir.97.15.1453 · Cited by 618 · see citing works

Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

Gotto, A. M., Whitney, E. J., Stein, E. A., Shapiro, D. R., Clearfield, M. B., Weis, S. E., Jou, J. Y., Langendörfer, A., Beere, P. A., Watson, D. J., et al. (2000) · Circulation · doi:10.1161/01.cir.101.5.477 · Cited by 562 · see citing works

High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

Walldius, G., Jungner, I., Holme, I., AASTVEIT, A. H., Kolar, W., & Steiner, E. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00666-9 · Cited by 534 · see citing works

European guidelines on cardiovascular disease prevention in clinical practice

Backer, G. D., Ambrosioni, E., Borch‐Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. D., Mancia, G., et al. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.10.001 · Cited by 493 · see citing works

Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study

Lamarche, B., Moorjani, S., Lupien, P. J., Cantin, B., Bernard, P.-M., Dagenais, G. R., & Despre´s, J.-P. (1996) · Circulation · doi:10.1161/01.cir.94.3.273 · Cited by 476 · see citing works

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

Sniderman, A. D., Furberg, C. D., KEECH, A. C., van Lennep, J. R., Frohlich, J., Jungner, I., & Walldius, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12663-3 · Cited by 457 · see citing works

Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men: 13-Year Follow-Up Data From the Québec Cardiovascular Study

St-Pierre, A. C., Cantin, B., Dagenais, G. R., Mauriège, P., Bernard, P.-M., Després, J.-P., & Lamarche, B. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000154144.73236.f4 · Cited by 422 · see citing works

Apolipoprotein B and apolipoprotein A‐I: risk indicators of coronary heart disease and targets for lipid‐modifying therapy

Walldius, G., & Jungner, I. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01276.x · Cited by 395 · see citing works

Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes

Lu, W., Resnick, H. E., Jablonski, K. A., Jones, K. L., Jain, A. K., Howard, W. J., Robbins, D. C., & Howard, B. V. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.16 · Cited by 370 · see citing works

International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material

Marcovina, S. M., Albers, J. J., Henderson, L. O., & Hannon, W. H. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.5.773 · Cited by 342 · see citing works

Low-Density Lipoprotein, Non-High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering Therapy

Grundy, S. M. (2002) · Circulation · doi:10.1161/01.cir.0000038419.53000.d6 · Cited by 309 · see citing works

Thrombogenic Factors and Recurrent Coronary Events

Moss, A. J., Goldstein, R. E., Marder, V. J., Sparks, C. E., Oakes, D., Greenberg, H., Weiss, H. J., Zaręba, W., Brown, M. W., Liang, C., et al. (1999) · Circulation · doi:10.1161/01.cir.99.19.2517 · Cited by 281 · see citing works

Relationship Between Lipid Levels and Clinical Outcomes in the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Trial

Simes, R. J., Marschner, I. C., Hunt, D. U., Colquhoun, D., SULLIVAN, D. R., Stewart, R., Hague, W. E., KEECH, A. C., Thompson, P., White, H. D., et al. (2002) · Circulation · doi:10.1161/hc1002.105136 · Cited by 250 · see citing works

Multivariate Assessment of Lipid Parameters as Predictors of Coronary Heart Disease Among Postmenopausal Women

Shai, I., Rimm, E. B., Hankinson, S. E., Curhan, G. C., Manson, J. E., Rifai, N., Stampfer, M. J., & Ma, J. (2004) · Circulation · doi:10.1161/01.cir.0000146339.57154.9b · Cited by 235 · see citing works

Nonfasting Apolipoprotein B and Triglyceride Levels as a Useful Predictor of Coronary Heart Disease Risk in Middle-Aged UK Men

Talmud, P. J., Hawe, E., Miller, G. J., & Humphries, S. E. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000035521.22199.c7 · Cited by 233 · see citing works

Non-HDL Cholesterol and Apolipoprotein B Predict Cardiovascular Disease Events Among Men With Type 2 Diabetes

Jiang, R., Schulze, M. B., Li, T., Rifai, N., Stampfer, M. J., Rimm, E. B., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1991 · Cited by 232 · see citing works

International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B

Marcovina, S. M., Albers, J. J., Dati, F., Ledue, T. B., & Ritchie, R. F. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.10.1676 · Cited by 228 · see citing works

Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk

Sniderman, A. D., St-Pierre, A. C., Cantin, B., Dagenais, G. R., Després, J.-P., & Lamarche, B. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00262-5 · Cited by 224 · see citing works

Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels

Ballantyne, C. M., Andrews, T. C., Hsia, J. A., Kramer, J. H., & Shear, C. L. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01638-1 · Cited by 166 · see citing works

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

LaRosa, J. C., Grundy, S. M., & Waters, D. D. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.10.023 · Cited by 165 · see citing works

Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events

van Lennep, J. E. R., Westerveld, H. T., van Lennep, H. W. O. R., Zwinderman, A. H., Erkelens, D. W., & van der Wall, E. E. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2408 · Cited by 152 · see citing works

Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study

Meisinger, C., Loewel, H., Wilfried, M. R. A. Z., & Köenig, W. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi003 · Cited by 142 · see citing works

The Friedewald Formula Underestimates LDL Cholesterol at low Concentrations

Scharnagl, H., Nauck, M. A., Wieland, H., & März, W. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.068 · Cited by 140 · see citing works

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

Auer, J., Weber, T., & Eber, B. (2004) · New England Journal of Medicine · doi:10.1056/nejm200408123510719 · Cited by 122 · see citing works

Lipids and CVD management: towards a global consensus

Ballantyne, C. M., Arroll, B., & Shepherd, J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi373 · Cited by 86 · see citing works

A proposal to redefine familial combined hyperlipidaemia – Third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the Scientific Sessions of the European Society for Clinical Investigation

Sniderman, A. D., Cabezas, M. C., Ribalta, J., Carmena, R., de Bruin, T. W., Graaf, J. D., Erkelens, D. W., Humphries, S. E., Masana, L., Real, J. T., et al. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00941.x · Cited by 81 · see citing works

How, when, and why to use apolipoprotein B in clinical practice

Sniderman, A. D. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02633-4 · Cited by 66 · see citing works

Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men

Simon, A. C., Chironi, G. N., Gariépy, J., Pino, M. D., & Levenson, J. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.017 · Cited by 49 · see citing works

Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies

Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · Clinical Science · doi:10.1042/cs20040108 · Cited by 48 · see citing works

Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes

Schulze, M. B., Shai, I., Manson, J. E., Li, T., Rifai, N., Jiang, R., & Hu, F. B. (2004) · Diabetologia · doi:10.1007/s00125-004-1593-2 · Cited by 43 · see citing works

Cardiovascular disease and hyperlipidaemia

Krauss, R. M., & niemi, Y. A. K. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199408000-00001 · Cited by 24 · see citing works

Comparison of the Relationships between Serum Apolipoprotein B and Serum Lipid Distributions

Kim, B. J., Hwang, S. T., Sung, K., Kim, B. S., Kang, J. H., Lee, M. H., & Park, J. R. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.052738 · Cited by 22 · see citing works

Apolipoproteins: the new prognostic indicator?

PACKARD, C. (2003) · European Heart Journal Supplements · doi:10.1016/s1520-765x(03)90032-0 · Cited by 19 · see citing works

The role of the cardiovascular specialist in the prevention of cardiovascular diseases - executive summary.

Collins-Nakai, R. L., & Dagenais, G. R. (1999) · PubMed · Cited by 18 · see citing works

Relationship between lipid levels and clinical outcomes in the long-term intervention with pravastatin in ischemic disease (LIPID) trial. To what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

Simes, R. J., Marschner, I. C., & Hunt, D. U. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00772-9 · Cited by 15 · see citing works

Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

&NA; (1998) · The Endocrinologist · doi:10.1097/00019616-199809000-00022 · Cited by 13 · see citing works

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

Sniderman, A. D., Furberg, C. D., KEECH, A. C., van Lennep, J. E. R., Frohlich, J., Jungner, I., Walldius, G., & Wägner, A. M. (2004) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(04)78954-8 · Cited by 9 · see citing works

Cardiovascular disease and hyperlipidaemia

Neary, R. H. (1993) · Current Opinion in Lipidology · doi:10.1097/00041433-199310000-00014 · Cited by 1 · see citing works

Indian Journal of Public Health Research & Development

Surwade, V. M., Ambedkar, B. S., Rohinee, & Delhi (2019) · Cited by 404 · see citing works

Ellagitannins, ellagic acid and vascular health

Larrosa, M., García‐Conesa, M., Espı́n, J. C., & Tomás-Barberán, F. A. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.09.005 · Cited by 378 · see citing works

Mechanisms of Action of trans Fatty Acids

Oteng, A., & Kersten, S. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz125 · Cited by 309 · see citing works

Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force

Haney, E. M., Huffman, L. H., Bougatsos, C., Freeman, M., Steiner, R. D., & Nelson, H. D. (2007) · PEDIATRICS · doi:10.1542/peds.2006-1801 · Cited by 202 · see citing works

Apolipoproteins and cancer

Ren, L., Yi, J., Li, W., Zheng, X., Liu, J., Wang, J., & Du, G. (2019) · Cancer Medicine · doi:10.1002/cam4.2587 · Cited by 145 · see citing works

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness

Makover, M. E., Shapiro, M. D., & Toth, P. P. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100371 · Cited by 133 · see citing works

Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study

Okamura, T., Kokubo, Y., Watanabe, M., Higashiyama, A., Miyamoto, Y., Yoshimasa, Y., & Okayama, A. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.020 · Cited by 123 · see citing works

The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques

Rai, V., & Agrawal, D. K. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0664 · Cited by 103 · see citing works

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes

on behalf of the FIELD study investigators, Taskinen, M.-R., Barter, P. J., Ehnholm, C., Sullivan, D. R., Mann, K., Simes, J., Best, J. D., Hamwood, S., & Keech, A. C. (2010) · Diabetologia · doi:10.1007/s00125-010-1806-9 · Cited by 94 · see citing works

Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke

Walldius, G., & Jungner, I. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3281bd8849 · Cited by 76 · see citing works

MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?

Burnett, J. R., & Watts, G. F. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.2.181 · Cited by 58 · see citing works

Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial

Lerman, R. H., Minich, D. M., Darland, G. K., Lamb, J. J., Schiltz, B., Babish, J. G., Bland, J. S., & Tripp, M. L. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-29 · Cited by 57 · see citing works

Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment

Galimberti, F., Casula, M., & Olmastroni, E. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106873 · Cited by 63 · see citing works

Exercise training ameliorates the effects of rosiglitazone on traditional and novel cardiovascular risk factors in patients with type 2 diabetes mellitus

Kadoglou, N. P. E., Iliadis, F. S., Sailer, N., Athanasiadou, Z. S., Vitta, I., Kapelouzou, A., Karayannacos, P. E., Liapis, C. D., Alevizos, M., Angelopoulou, N., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.09.002 · Cited by 55 · see citing works

Genetic variation in PNPLA3 but not APOC3 influences liver fat in non‐alcoholic fatty liver disease

Hyysalo, J., Stojkovic, I., Kotronen, A., Hakkarainen, A., Sevastianova, K., Makkonen, J., Lundbom, N. M. I., Rissanen, A., Krauss, R. M., Melander, O., et al. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07045.x · Cited by 53 · see citing works

The Transcription Profile Unveils the Cardioprotective Effect of Aspalathin against Lipid Toxicity in an In Vitro H9c2 Model

Johnson, R., Dludla, P. V., Muller, C. J. F., Huisamen, B., Essop, M. F., & Louw, J. (2017) · Molecules · doi:10.3390/molecules22020219 · Cited by 53 · see citing works

Genetic Dominance Influences Blood Biomarker Levels in a Sample of 12,000 Swedish Elderly Twins

Rahman, I., Bennet, A. M., Pedersen, N. L., Fairé, U. D., Svensson, P., & Magnusson, P. K. E. (2009) · Twin Research and Human Genetics · doi:10.1375/twin.12.3.286 · Cited by 48 · see citing works

Acute effects of vinegar intake on some biochemical risk factors of atherosclerosis in hypercholesterolemic rabbits

Setorki, M., Asgary, S., Eidi, A., Rohani, A. H., & Khazaei, M. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-10 · Cited by 50 · see citing works

Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I – new risk factors and targets for therapy

Walldius, G., & Jungner, I. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.02.010 · Cited by 48 · see citing works

Dyslipidemia and Its Role in the Pathogenesis of Atherosclerotic Cardiovascular Disease: Implications for Evaluation and Targets for Treatment of Dyslipidemia Based on Recent Guidelines

Wengrofsky, P., Lee, J., & Makaryus, A. N. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85772 · Cited by 50 · see citing works

Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non‐alcoholic fatty liver disease

Wu, C., Zhao, S., & Yu, B. (2014) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12116 · Cited by 44 · see citing works

Future Challenges for Microsomal Transport Protein Inhibitors

Wierzbicki, A. S., Hardman, T. C., & Prince, W. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109788340703 · Cited by 45 · see citing works

Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease

Sfyri, P., & Matsakas, A. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0346-8 · Cited by 43 · see citing works

O-Glycoside Biomarker of Apolipoprotein C3: Responsiveness to Obesity, Bariatric Surgery, and Therapy with Metformin, to Chronic or Severe Liver Disease and to Mortality in Severe Sepsis and Graft vs Host Disease

Harvey, S. B., Zhang, Y., Wilson‐Grady, J., Monkkonen, T., Nelsestuen, G. L., Kasthuri, R. S., Verneris, M. R., Lund, T. C., Ely, E. W., Bernard, G. R., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr800751x · Cited by 43 · see citing works

The Visceral Adiposity Index: Relationship with cardiometabolic risk factors in obese and overweight postmenopausal women – A MONET group study

Elisha, B., Messier, V., Karelis, A. D., Coderre, L., Bernard, S., Prud’homme, D., & RABASA-LHORET, R. P. R. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0307 · Cited by 42 · see citing works

Special Supplemental Nutrition Program For Women, Infants, and Children

Guide, C. W. F. (2011) · Cited by 42 · see citing works

The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia

Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.001 · Cited by 40 · see citing works

Biochemical markers for cardiovascular disease in recently postmenopausal women with or without hot flashes

Tuomikoski, P., Mikkola, T. S., Hämäläinen, E. K., Tikkanen, M. J., Turpeinen, U., & Ylikorkala, O. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181acefd5 · Cited by 33 · see citing works

Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo

Watts, G. F., Ooi, E. M. M., & Chan, D. C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.04.005 · Cited by 33 · see citing works

Estimating the Effect of Aerobic Exercise Training on Novel Lipid Biomarkers: A Systematic Review and Multivariate Meta-Analysis of Randomized Controlled Trials

Wood, G., Taylor, E., Ng, V., Murrell, A., Patil, A., van der Touw, T., Wolden, M., Andronicos, N., & Smart, N. A. (2023) · Sports Medicine · doi:10.1007/s40279-023-01817-0 · Cited by 31 · see citing works

Índice apo B/apo A-I e predição de risco cardiovascular

Lima, L. M., Ferriani, M. D. G. C., & Sousa, M. O. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007000600014 · Cited by 31 · see citing works

Efficacy of new beverage made of dates vinegar and garlic juice in improving serum lipid profile parameters and inflammatory biomarkers of mildly hyperlipidemic adults: A double-blinded, randomized, placebo-controlled study

Ali, Z., Ma, H., Ayim, I., & Wali, A. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12545 · Cited by 28 · see citing works

Menopausal hot flushes and vascular health

Tuomikoski, P., Ylikorkala, O., & Mikkola, T. S. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.546364 · Cited by 28 · see citing works

Apolipoprotein B is related to arterial pulse wave velocity in young adults: The Cardiovascular Risk in Young Finns Study

Koivistoinen, T., Hutri‐Kähönen, N., Juonala, M., Kööbi, T., Aatola, H., Lehtimäki, T. J., Viikari, J. S. A., Raitakari, O. T., & Kähönen, M. A. P. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.037 · Cited by 27 · see citing works

ApoE Genotype, Lipid Profile, Exercise, and the Associations With Cardiovascular Morbidity and 18-Year Mortality

Dankner, R. S., Avraham, S. B., Harats, D., & Chetrit, A. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz232 · Cited by 27 · see citing works

Lipid Profile, Apolipoproteins A and B in Children With Epilepsy

Tomoum, H. Y., Awadallah, M., Fouad, D. A., & Ali, A. H. (2008) · Journal of Child Neurology · doi:10.1177/0883073808318538 · Cited by 25 · see citing works

The strengths and limitations of the ApoB/ApoA-I ratio to predict the risk of vascular disease: a hegelian analysis

Sniderman, A. D., & Kiss, R. S. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0031-6 · Cited by 22 · see citing works

Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review

Bagherniya, M., Johnston, T. P., & Sahebkar, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200427092114 · Cited by 21 · see citing works

Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases

Sturm, E. M., Knuplez, E., & Marsche, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094377 · Cited by 21 · see citing works

Serum Metabolomics Study of Gliclazide-Modified-Release-Treated Type 2 Diabetes Mellitus Patients Using a Gas Chromatography–Mass Spectrometry Method

Zhou, Y., Hu, C., Zhao, X., Luo, P., Lu, J., Li, Q., Chen, M., Yan, D., Lu, X., Kong, H., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00866 · Cited by 21 · see citing works

Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case–Control Study

Wu, T., Zheng, Y., Yang, Y., Li, X., Ma, Y.-T., & Xie, X. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0067 · Cited by 21 · see citing works

Molecular signatures of atherosclerotic plaques: An up-dated panel of protein related markers

Eslava-Alcón, S., Extremera-García, M. J., González-Rovira, A., Rosal‐Vela, A., Rojas-Torres, M., Beltrán-Camacho, L., Sánchez-Gomar, I., Jiménez-Palomares, M., Alonso-Piñero, J. A., Conejero, R. C., et al. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103757 · Cited by 21 · see citing works

Low serum adiponectin levels are associated with reduced insulin sensitivity and lipid disturbances in short children born small for gestational age

Huang, Y., Li, Y., Chen, Q., Chen, H.-S., Ma, H., Su, Z., & Du, M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12663 · Cited by 20 · see citing works

How Do Apolipoproteins ApoB and ApoA-I Perform in Patients with Acute Coronary Syndromes

Sypniewska, G., Bergmann, K., Krintus, M., Koziński, M., & Kubica, J. (2011) · Journal of Medical Biochemistry · doi:10.2478/v10011-011-0022-6 · Cited by 19 · see citing works

Serum proteome profiling in canine chronic valve disease using a TMT-based quantitative proteomics approach

Kuleš, J., Bilić, P., Horvatić, A., Kovačević, A., Guillemin, N., Ljubić, B. B., Galán, A., Jović, I., Torti, M., Rubić, I., et al. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103825 · Cited by 18 · see citing works

Randomized placebo-controlled trial of Mustadi Ghanavati in hyperlipidemia

Nadkarni, M., Vyas, S., Baghel, M., & Ravishankar, B. (2010) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/0974-8520.77150 · Cited by 17 · see citing works

Relevance of Lipoprotein Composition in Endothelial Dysfunction and the Development of Hypertension

Ramírez-Melo, L. M., Estrada-Luna, D., Rubio-Ruiz, M. E., Ovando, A. C., Fernández‐Martínez, E., Jiménez‐Osorio, A. S., Pérez-Méndez, O. A., & Carreón‐Torres, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031125 · Cited by 14 · see citing works

Polimorfismos de los genes APOA1 y APOB y concentraciones de sus apolipoproteínas como biomarcadores de riesgo en el síndrome coronario agudo: relación con la efectividad del tratamiento hipolipemiante

Casillas-Muñoz, F. A. G., Valle, Y., Muñóz-Valle, J. F., Martínez-Fernández, D. E., Reynoso-Villalpando, G. L., Flores-Salinas, H. E., Llamas-Covarrubias, M. A., & Padilla‐Gutiérrez, J. R. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.07.026 · Cited by 14 · see citing works

Acute modification in plasma lipid levels in ultramarathon runners

Emed, L. G. M., Passaglia, D. G., Guerios, S. T., David-João, P. G., Moser, A. I., Abdalla, D. S. P., Guarita-Souza, L. C., Mikilita, E. S., Baena, C. P., da Costa, A. B. B. A., et al. (2015) · Journal of Sports Sciences · doi:10.1080/02640414.2015.1130237 · Cited by 14 · see citing works

APOA1 and APOB polymorphisms and apolipoprotein concentrations as biomarkers of risk in acute coronary syndrome: Relationship with lipid-lowering therapy effectiveness

Casillas-Muñoz, F. A. G., Valle, Y., Muñóz-Valle, J. F., Martínez-Fernández, D. E., Reynoso-Villalpando, G. L., Flores-Salinas, H. E., Llamas-Covarrubias, M. A., & Padilla‐Gutiérrez, J. R. (2018) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.05.001 · Cited by 14 · see citing works

Apolipoprotein B Levels Predict Future Development of Hypertension Independent of Visceral Adiposity and Insulin Sensitivity

Han, S. J., Fujimoto, W. Y., Kahn, S. E., Leonetti, D. L., & Boyko, E. J. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.2.351 · Cited by 13 · see citing works

Impact of an integrated obesity management system on patient’s care - research protocol

Baillargeon, J., Tribble, D. S., Xhignesse, M., Grant, A., Brown, C., & Langlois, M. (2014) · BMC Obesity · doi:10.1186/s40608-014-0019-z · Cited by 13 · see citing works

The Use of Biomarkers for the Early Detection of Vulnerable Atherosclerotic Plaques and Vulnerable Patients. A Review

Benedek, T., Maurovich‐Horvat, P., Ferdinandy, P., & Merkely, B. P. (2016) · Journal of Cardiovascular Emergencies · doi:10.1515/jce-2016-0017 · Cited by 12 · see citing works

Dietary oil modifies the plasma proteome during aging in the rat

González, M. S., López‐Miranda, J., Pérez‐Jiménez, F., Navas, P., & Villalba, J. M. (2011) · AGE · doi:10.1007/s11357-011-9239-z · Cited by 12 · see citing works

High prevalence of subclinical atherosclerosis in Brazilian postmenopausal women with low and intermediate risk by Framingham score

Petisco, A. C. G. P., Assef, J. E., de Jesus, C. A., Saleh, M. H., Barbosa, J. E. M., Bihan, D. C. D. S. L., Pinto, I. F. M., Pedra, S. R. F. F., Barretto, R. B. D. M., & Sousa, A. (2016) · International journal of cardiac imaging · doi:10.1007/s10554-016-1002-1 · Cited by 11 · see citing works

Lipids and atherosclerosis

Djerić, M., Stokić, E., Vučković, B., Kojić-Damjanov, S., & Čabarkapa, V. (2006) · Jugoslovenska medicinska biohemija · doi:10.2298/jmb0604325d · Cited by 11 · see citing works

Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy

Tuomikoski, P., Mikkola, T. S., Tikkanen, M. J., & Ylikorkala, O. (2010) · Climacteric · doi:10.3109/13697131003624656 · Cited by 11 · see citing works

The beneficial effects of HDL-C on atherosclerosis: rationale and clinical results

Santos‐Gallego, C. G., Torres, F., & Badimón, J. J. (2011) · Clinical Lipidology · doi:10.2217/clp.10.90 · Cited by 10 · see citing works

Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non–HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes

Weinstock, R. S., Goldberg, R. B., Guyton, J. R., Mazzone, T., Polis, A. B., Tomassini, J. E., Lin, J., Shah, A. K., & Tershakovec, A. M. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.01.001 · Cited by 9 · see citing works

Therapeutic effects of an aspalathin-rich green rooibos extract, pioglitazone and atorvastatin combination therapy in diabetic db/db mice

Patel, O., Muller, C. J. F., Joubert, E., Rosenkranz, B., Louw, J., & Awortwe, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251069 · Cited by 9 · see citing works

Reduces cholesterol induced atherosclerotic lesions in aorta artery in hypercholesterolemic rabbits

Setorki, M., Asgary, S., Javanmard, S. H., & Nazari, B. (2011) · Journal of Medicinal Plants Research · doi:10.5897/jmpr.9001077 · Cited by 9 · see citing works

Biochemical Markers of Atherosclerosis

Đerić, M., Kojić-Damjanov, S., Čabarkapa, V., & Eremić, N. (2008) · Journal of Medical Biochemistry · doi:10.2478/v10011-008-0008-1 · Cited by 9 · see citing works

Niveles plasmáticos de apolipoproteínas en una población saludable de la Argentina: implicaciones en prevención cardiovascular

Siniawski, D. A., Masson, W. M., Bluro, I. M., Sorroche, P. B., Scordo, W., Krauss, J. G., & Cagide, A. M. (2025) · Revista Argentina de Cardiología · doi:10.7775/rac.v77i2.2158 · Cited by 6 · see citing works

The association between eosinophil count, serum lipids and metabolic syndrome in Taiwanese

Lin, W., & Chen, J. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.07.015 · Cited by 7 · see citing works

Dyslipidemia in Obesity

Chan, D. C., Pang, J., & Watts, G. F. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_30 · Cited by 8 · see citing works

Low-density lipoprotein lowering in type 2 diabetes mellitus: how to know how low to go

Sniderman, A. D. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32809f951a · Cited by 7 · see citing works

Association Between Apo Lipoprotein B Levels at Admission of Patientsand Short-term Morbidity and Mortality After Myocardial Infarction

Sokhanvar, S., Khoshi, A., Hajiaghaei, S., Mousavinasab, S. N., & Golmohammadi, Z. (2012) · Europe PMC (PubMed Central) · doi:10.5681/jcvtr.2012.015 · Cited by 6 · see citing works

Serum 25-hydroxyvitamin D3 is associated with homocysteine more than with apolipoprotein B

Kim, N.-K., Jung, M.-A., Choi, B. H., & Joo, N. (2022) · Nutrition Research and Practice · doi:10.4162/nrp.2022.16.6.745 · Cited by 6 · see citing works

Role of FGF21 and Leptin for the Diagnosis of Metabolic Health in Children with and without Obesity

Domouzoglou, E. M., Vlahos, A. P., Papafaklis, M. I., Cholevas, V., Chaliasos, N., Siomou, E. C., Michalis, L. K., Tsatsoulis, A. A., & Naka, K. Κ. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13121680 · Cited by 5 · see citing works

Serum lipid profile constituents as markers of cardiovascular morbidity in patients on chronic hemodialysis.

Kirmizis, D. A., Koutoupa, E., Tsiandoulas, A., Valtopoulou, A., Niavis, G., Markou, P., & Barboutis, K. (2007) · PubMed Central · Cited by 5 · see citing works

Estimating LDL ApoB: Infomania or Clinical Advance?

Burnett, J. R., & Watts, G. F. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.104505 · Cited by 5 · see citing works

Evaluation of Lipid Metabolism among Sudanese Patients with Type 2 Diabetes Mellitus

Elfaki, E. M., Mohamed, E., Raheem, A., Ahmed, S. E., & Arabia, S. (2014) · Cited by 4 · see citing works

High-sensitivity C-reactive protein, apolipoproteins, and residual diuresis in chronic kidney disease patients undergoing hemodialysis

Borges, D. L., Lemes, H. P., Ferreira, V. D. C., & Filho, S. R. F. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-016-1230-7 · Cited by 4 · see citing works

Dyslipidemia in Obesity

Chan, D. C., Pang, J., & Watts, G. F. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_30-1 · Cited by 5 · see citing works

Bromuconazole exposure induces cardiac dysfunction by upregulating the expression LEF1

Huang, Y., Gu, W., Qin, Z., & Jin, Y. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.173113 · Cited by 4 · see citing works

Association of Paraoxonase1 Gene Q192R Polymorphism and Apolipoprotein B in Asian Indian Women with Coronary Artery Disease Risk

Deshpande, C. S., Singhal, R. S., & Mukherjee, M. S. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0193 · Cited by 4 · see citing works

Correlation between Apolipoprotein B-to-Apolipoprotein A1 Ratio and Total-to-HDL-Cholesterol Ratio in a Healthy Population: Should Castelli Index be Updated?

Siniawski, D. A., Masson, W. M., Sorroche, P. B., Casañas, L., & Krauss, J. G. (2011) · Dialnet (Universidad de la Rioja) · doi:10.7775/rac.79.1.554 · Cited by 3 · see citing works

The correlation between serum Apo lipoprotein A1 and Apo lipoprotein B with coronary artery disease and its severity

Mashaykhi, N. R., Sadrneya, S., Chehrei, A., Javaheri, J., & Ahmadlou, M. (2013) · مجله دانشگاه علوم پزشکی اراک · Cited by 3 · see citing works

Association Between Apolipoprotein B and Coronary Artery Disease Among Hypertensive Patients: A Systematic Review of the Prospective and Retrospective Studies

Nathir, I., Aziz, F. A., & Hashim, R. D. (2023) · Cureus · doi:10.7759/cureus.49854 · Cited by 2 · see citing works

Apolipoprotein L3 inhibits breast cancer proliferation and modulates cell cycle via the P53 pathway

Yu, H., Li, S., Li, X., Liu, Y., Wang, Z., Cui, M., Jin, F., & Yu, X. (2024) · Journal of Cancer · doi:10.7150/jca.96903 · Cited by 2 · see citing works

Microwave radiation exposures affect the ldl, hdl, tcl and trg status in rats

Aweda, M. A., Gbenebitse, S., & Meindinyo, R. O. K. (2010) · International Journal of the Physical Sciences · doi:10.5897/ijps.9000370 · Cited by 2 · see citing works

The Safety and Efficacy of Statin Therapy in the Pediatric Population

Robbins, D. A. (2011) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3181e19a82 · Cited by 2 · see citing works

Serum Lipid Profile Constituents as Markers of Cardiovascular Morbidity in Patients on Chronic Hemodialysis

Kirmizis, D. A., Koutoupa, E., Tsiandoulas, A., Valtopoulou, A., Niavis, G., Markou, P., & Barboutis, K. (2006) · Biomarker Insights · doi:10.1177/117727190600100010 · Cited by 6 · see citing works

Postmenopausal hot flushes, vascular health and hormone therapy

Tuomikoski, P. (2010) · Työväentutkimus Vuosikirja · Cited by 2 · see citing works

Biomarkers of Cardiovascular Disorders

Jain, K. K. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-685-6_8 · Cited by 1 · see citing works

Significance of Determining Levels of Apolipoproteins A-I and B in the Diagnostics and Assessment of Lipid-Related Atherogenic Risk in Hyperalpha-Lipoproteinemia, Hypocholesterolemia and Hypo-Hdl-Cholesterolemia

Kojić-Damjanov, S., Đerić, M., Čabarkapa, V., & Vučurević-Ristić, L. (2007) · Journal of Medical Biochemistry · doi:10.2478/v10011-007-0024-6 · Cited by 1 · see citing works

Evaluation of Endothelial Function in Pre-Menopausal Women With Coronary Arterial Disease

Farias, W. K. D. S., Rocha, T. P. O., de Melo, J. B., Fonseca, É. J. N. D. C., Fernandes, D. R., Pontes, L. P. P., Andrade, M. V. G., & Neto, J. A. D. F. (2017) · International Journal of Cardiovascular Sciences · doi:10.5935/2359-4802.20170043 · Cited by 1 · see citing works

Comparison of Apolipoprotein Concentrations and Values of APOB:APOAI with Traditional Lipid Measures in Women Diagnosed with Acute Cornonary Syndromes - A Preliminary Report.

Krintus, M., Bergmann, K., Sypniewska, G., & Sawicki, M. (2011) · PubMed Central · Cited by 1 · see citing works

Association of Apolipoprotein B and Triglyceride Levels with Coronary Artery Disease

Habib, H., Haroon, Z. H., Aamir, M. B., Bibi, A., Javed, H., & Jaffar, S. R. (2022) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v72i5.6114 · Cited by 1 · see citing works

Studies on the atherogenicity of apoB-containing lipoproteins in type 2 diabetes

Pettersson, C. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1 · see citing works

Inflamação, apolipoproteínas e diurese residual em pacientes com doença renal crônica em hemodiálise: um estudo observacional

Borges, D. L. (2014) · doi:10.14393/ufu.di.2018.3 · Cited by 1 · see citing works

Lipoprotein (a) in Sudanese diabetic patients correlated with glycosylated heamoglobin

Ahmed, E. M. (2014)

Análise da relação de qualidade da dieta com nível de atividade física e destes com perfil lipídico e estado inflamatório em indivíduos de risco cardiometabólico

Pires, M. M. (2011) · doi:10.11606/d.6.2011.tde-14092011-094751

Prevalência da aterosclerose subclínica em mulheres na pós-menopausa com risco cardiovascular baixo e intermediário estimado pelo escore de Framingham

Petisco, A. C. G. P. (2014) · doi:10.11606/t.98.2014.tde-15072014-090843

Programa de intervenção interdisciplinar em hábitos de vida em indivíduos de risco cardiometabólico: análise de fatores dietéticos associados à melhora do metabolismo glicídico

de Barros, C. R. (2012) · doi:10.11606/t.6.2012.tde-07112012-103357

Assessment of Lipoprotein (a) In Blood Samples of Sudanese Diabetic Patients Correlated With Glycosylated Heamoglobin

Ahmed, E. M., & Mohamed, A. O. (2014)

Biomarcadores relevantes para diagnóstico precoce e prevenção de doenças cardiovasculares.

Queiroz, J. C. S. (2014)

SIGNIFICANCE OF DETERMINING LEVELS OF APOLIPOPROTEINS A-I AND B IN THE DIAGNOSTICS AND ASSESSMENT OF LIPID-RELATED ATHEROGENIC RISK IN HYPERALPHA-LIPOPROTEINEMIA, HYPOCHOLESTEROLEMIA AND HYPO-HDL-CHOLESTEROLEMIA ZNA^AJ ODRE\IVANJA NIVOA APOLIPOPROTEINA A-I I B U DIJAGNOSTICI I PROCENI ATEROGENOG RIZIKA LIPIDSKOG POREKLA U HIPERALFA-LIPOPROTEINEMIJI, HIPOHOLESTEROLEMIJI I HIPO-HDL-HOLESTEROLEMIJI

Vu, L. (2007)

Análise da relação de qualidade da dieta com nível de atividade física e destes com perfil lipídico e estado inflamatório em indivíduos de risco cardiometabólico

Pública, F. D. S. (2011)

Review Apolipoproteins as markers and managers of coronary risk

Chan, D. C., & Watts, G. F. (2015)

Moving Beyond LDL-C and Non-HDL-C: Apolipoprotein B as the Stronger Lipid-Related Predictor of Coronary Artery Disease in Statin-Treated Patients

Jigoranu, A. R., Mitu, O., Costache, A. D., Oancea, A. F., Miftode, R.-Ş., Buburuz, A. M., Bazyani, A., Simion, P., Gavril, R. S., Cianga, P., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15233002 · Cited by 2 · see citing works

Apolipoprotein B and apolipoprotein A‐I: risk indicators of coronary heart disease and targets for lipid‐modifying therapy

Walldius, G., & Jungner, I. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01276.x · Cited by 395 · see citing works

Coronary heart disease prediction: Apolipoprotein B shows its might again – but still in vain?

Kovanen, P. T., & Jauhiainen, M. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315580892 · Cited by 7 · see citing works

Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I – new risk factors and targets for therapy

Walldius, G., & Jungner, I. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.02.010 · Cited by 48 · see citing works